{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T21:50:58Z","timestamp":1792705858522,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1053\/j.ajkd.2008.06.023","type":"journal-article","created":{"date-parts":[[2008,9,19]],"date-time":"2008-09-19T04:45:32Z","timestamp":1221799532000},"page":"661-671","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":223,"title":["Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred Cohort"],"prefix":"10.1053","volume":"52","author":[{"given":"Adeera","family":"Levin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ognjenka","family":"Djurdjev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 7","key":"10.1053\/j.ajkd.2008.06.023_bib1","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/ndt\/16.suppl_7.57","article-title":"Identification of patients and risk factors in chronic kidney disease\u2014Evaluating risk factors and therapeutic strategies","volume":"16","author":"Levin","year":"2001","journal-title":"Nephrol Dial Transplant"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2008.06.023_bib2","first-page":"S47","article-title":"USRDS 2006 Annual Data Report","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.06.023_bib3","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"10.1053\/j.ajkd.2008.06.023_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0272-6386(03)00916-8","article-title":"A population-based study of the incidence and outcomes of diagnosed chronic kidney disease","volume":"42","author":"Drey","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"suppl 2","key":"10.1053\/j.ajkd.2008.06.023_bib5","first-page":"S1","article-title":"K\/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.06.023_bib6","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood pressure control on the progression of chronic renal disease","volume":"330","author":"Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.06.023_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-142-5-200503010-00009","article-title":"The effect of a lower target blood pressure on the progression of kidney disease: Long-term follow-up of the Modification of Diet in Renal Disease Study","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.ajkd.2008.06.023_bib8","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.ki.5000058","article-title":"The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age","volume":"69","author":"Eriksen","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.06.023_bib10","first-page":"906","article-title":"Slowing the progression of chronic renal insufficiency","volume":"166","author":"Tonelli","year":"2002","journal-title":"CMAJ"},{"key":"10.1053\/j.ajkd.2008.06.023_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1093\/ndt\/gfh585","article-title":"The short and long term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes","volume":"20","author":"Curtis","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.06.023_bib12","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1046\/j.1523-1755.2003.00885.x","article-title":"The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL Study","volume":"63","author":"Keane","year":"2003","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.06.023_bib13","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.06.023_bib16","first-page":"413","article-title":"Elevated levels of serum creatinine: Recommendations for management and referral","volume":"161","author":"Mendelssohn","year":"1999","journal-title":"CMAJ"},{"key":"10.1053\/j.ajkd.2008.06.023_bib17","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.06.023_bib18","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ndt\/15.5.650","article-title":"Predictors of hospitalization and death among pre-dialysis patients: A retrospective cohort study","volume":"15","author":"Holland","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"10.1053\/j.ajkd.2008.06.023_bib19","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2008.06.023_bib20","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.06.023_bib21","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(98)04433-X","article-title":"Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial","volume":"352","author":"Ruggenenti","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2008.06.023_bib22","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1053\/ajkd.2001.22070","article-title":"Cardiac risk factors and use of cardioprotective medications in patients with chronic renal insufficiency","volume":"37","author":"Tonelli","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"suppl 1","key":"10.1053\/j.ajkd.2008.06.023_bib23","first-page":"S248","article-title":"KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Vascular Access, Update 2006","volume":"48","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.06.023_bib24","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMoa022536","article-title":"Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy","volume":"349","author":"Teng","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ajkd.2008.06.023_bib25","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1681\/ASN.2004070573","article-title":"Activated injectable vitamin D and hemodialysis survival: A historical cohort study","volume":"16","author":"Teng","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.06.023_bib26","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.06.023_bib27","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1111\/j.1523-1755.2005.00651.x","article-title":"Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease?","volume":"68","author":"Levin","year":"2005","journal-title":"Kidney Int"},{"key":"10.1053\/j.ajkd.2008.06.023_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1053\/j.ajkd.2003.12.046","article-title":"Unreferred chronic kidney disease: A longitudinal study","volume":"43","author":"John","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.06.023_bib29","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1681\/ASN.2006040368","article-title":"Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease","volume":"17","author":"Ma","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1053\/j.ajkd.2008.06.023_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1053\/j.ajkd.2004.11.012","article-title":"Application of GFR-estimating equations in Chinese patients with chronic kidney disease","volume":"45","author":"Zuo","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1053\/j.ajkd.2008.06.023_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10157-006-0453-4","article-title":"Estimation of glomerular filtration rate by the MDRD study equation modified for Japaense patients with chronic kidney disease","volume":"11","author":"Imai","year":"2007","journal-title":"Clin Exp Nephrol"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608011049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638608011049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:50:03Z","timestamp":1759456203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638608011049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0272638608011049"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.06.023","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1123994.581104","asserted-by":"object"}]},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred Cohort","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2008.08.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}